Physician profile
Iris B Bernstein
NPI 1386673093
$6,323.57
in general payments reported to CMS, 2019-2025
35 companies · $19.41 in 2025
The $19.41 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $1,003 · 2021: $1,094 · 2022: $1,467 · 2023: $1,616 · 2024: $692 · 2025: $19.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629 · Travel and Lodging: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.31 |
| Travel and Lodging | $698.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,995.13 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $1,029.65 | 2019-2020 | |
| Coloplast Corp | $481.96 | 2019-2024 | Titan |
| Astellas Pharma US INC | $462.82 | 2019-2024 | Xtandi |
| Caldera Medical, INC | $346.46 | 2022-2023 | Desara |
| Axonics, INC. | $204.92 | 2020-2024 | Axonics, Bulkamid |
| Astrazeneca Pharmaceuticals LP | $196.09 | 2022-2023 | Lynparza |
| Medtronic, INC. | $180.96 | 2021-2023 | Interstim |
| Novartis Pharmaceuticals Corporation | $122.07 | 2024 | |
| 180 Medical, INC. | $121.37 | 2019-2023 | Gentlecath |
| Boston Scientific Corporation | $116.99 | 2020-2023 | Tria Firm, Solyx Sis System |
| Nalu Medical, INC. | $105.35 | 2023 | Nalu Neurostimulation System |
| Therapeuticsmd, INC. | $101.07 | 2019-2021 | |
| Horizon Therapeutics Plc | $92.99 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $84.96 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $83.49 | 2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $74.61 | 2020-2022 | |
| Abbvie INC. | $67.89 | 2022-2024 | Lupron Depot |
| Convatec INC. | $63.41 | 2021-2023 | |
| Procept Biorobotics Corporation | $45.43 | 2022 | |
| Merck Sharp & Dohme LLC | $44.64 | 2024 | Keytruda |
| Allergan, INC. | $41.15 | 2021 | |
| Myovant Sciences INC. | $34.15 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $25.72 | 2022-2023 | Prolaris |
| Hollister Incorporated | $24.62 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $22.08 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.03 | 2024 | Adstiladrin |
| Urovant Sciences INC | $21.31 | 2021 | |
| Blue Earth Diagnostics | $20.61 | 2021 | |
| Rochester Medical Corporation | $18.41 | 2021 | |
| Medtronic USA, INC. | $17.53 | 2020 | |
| Valencia Technologies Corporation | $15.52 | 2022 | |
| Cook Medical LLC | $13.97 | 2024 | Cook |
| Progenics Pharmaceuticals, INC. | $13.15 | 2023 | Pylarify |
| Pfizer INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.